Welcome
Support Centre
13 October 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Double-blind, placebo-controlled crossover trial of inhaled oxygen in the treatment of acute cluster headache
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN94092997
Date ISRCTN assigned15/06/2007
Local reference number(s)CHO2
Public titleDouble-blind, placebo-controlled crossover trial of inhaled oxygen in the treatment of acute cluster headache
Scientific title
AcronymCHAO2
Disease/condition/study domainCluster headache
Study hypothesisOxygen is a more effective treatment of acute cluster headache than air.
Design/methodologyDouble-blind, placebo-controlled, cross-over randomised trial.
Research ethics reviewThe National Hospital for Neurology and Neurosurgery, approved on 3 March 2003 (ref: 01/N122)
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Active Cluster headache
2. Attack duration between 45 minutes and three hours
Participants - exclusion criteria1. Pregnant and lactating women will be excluded
2. Patients with moderate to severe chronic obstructive pulmonary disease will be excluded as the high-dose high-flow oxygen may affect their hypoxic respiratory drive.
3. Patients who cannot tolerate the oxygen mask in the correct fitting will be excluded from the study
Patient information material
Anticipated start date02/04/2003
Anticipated end date30/04/2007
Status of trialCompleted
Target number of participants55
InterventionsTreatment of acute cluster headache with inhaled air or oxygen. Each participant will be randomised to treatment sequence of either AB or BA, where A is oxygen and B is inhaled air.
Primary outcome measure(s)Proportion of patients pain free after 15 minutes of treatment comparing oxygen and air.
Secondary outcome measure(s)1. Rendering the patient pain free at 30 minutes
2. Reduction in pain scale at 15, 30, 45 and 60 minutes
3. Need for rescue medication from 15 minutes after treatment
4. Overall response to the treatment and overall functional disability
5. Effect on associated symptoms
Sources of fundingBOC Gases (International)
Sponsor nameBOC Ltd (UK)
Sponsor detailsChertsey Road
Windlesham
Surrey
United Kingdom
GU20
Sponsor websitehttp://www.boc-gases.com/
Contact nameProf Peter Goadsby
Contact detailsInstitute of Neurology
Queen Square
London
United Kingdom
WC1N 3BG
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN94092997
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central